Medical Condition News

RSS

New MRI technique could pave the way to quicker assessment of multiple sclerosis

It is important that multiple sclerosis (MS) is diagnosed and treated as early as possible in order to delay progression of the disease.

18 Jan 2022

New pathways responsible for hepatocellular carcinoma identified

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It is one of leading causes of cancer-related deaths globally, with more than 700,000 new cases and 600,000 estimated HCC deaths each year.

18 Jan 2022

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.

18 Jan 2022

Risk factors affect cardiovascular disease risk even in patients with no coronary artery calcium

Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension nonetheless have the highest risk of cardiovascular disease events, according to a study published in the journal Circulation.

18 Jan 2022

NIH launches first phase of the Neuromod Prize to develop new neuromodulation therapies

The National Institutes of Health has launched the first phase of the Neuromod Prize, a $9.8 million competition to accelerate the development of neuromodulation therapies — targeted treatments that adjust nerve activity to improve organ function.

18 Jan 2022

In-jail buprenorphine treatment for opioid use disorder may reduce rearrest and reconviction

A study conducted in two rural Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved to treat opioid use disorder, known as buprenorphine, were less likely to face rearrest and reconviction after release than those who did not receive the medication.

18 Jan 2022

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

In a preliminary study of 106 people with "wet" age-related macular degeneration, Johns Hopkins Medicine researchers report that as many as a third of those with the blinding retinal disease may someday be able to safely stop eye injection therapy without further vision loss.

18 Jan 2022

Arterial stiffness in adolescence may be a causal risk factor for insulin resistance and dyslipidemia

Arterial stiffness may be a novel risk factor to be targeted in the prevention and treatment of insulin resistance and dyslipidemia from a young age, a new study published in Hypertension today suggests.

18 Jan 2022

Wastewater-based epidemiology to predict emerging new SARS-CoV-2 variants

In a new study, researchers established a strong approach for deducing public health-relevant epidemiological metrics like relative variant abundance and variant-specific reproduction numbers from wastewater (WW)-derived deep sequenced SARS-CoV-2 genomes.

18 Jan 2022

Chinese scientists reveal key role of lysosome cell death regulator in lung tumor survival

Chinese scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in tumor survival, providing a potential diagnostic and therapeutic target for lung cancer.

18 Jan 2022

ACP guidelines: Uncomplicated diverticulitis can be treated in an outpatient setting without antibiotics

According to two new clinical guidelines from the American College of Physicians, uncomplicated diverticulitis can be treated in an outpatient setting without antibiotics.

18 Jan 2022

New blood test for glioblastoma diagnosis may soon be a reality

Researchers at the University of Sussex are one step further to developing a blood test capable of diagnosing the most aggressive form of brain tumor.

18 Jan 2022

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

In a new study, a team of researchers estimated the pre-pandemic incidence rates of adverse events of special interest now observed in association with COVID-19 vaccines in Canada.

18 Jan 2022

DPP4 protein: The connection between severe COVID-19 and diabetes

Researchers explore the relationship between DPP4 and diabetes targets in the management of COVID-19.

17 Jan 2022

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Researchers prevent evidence on the efficacy of neutralizing monoclonal antibodies in treating COVID-19.

17 Jan 2022

Effects of post-acute COVID-19 on physical and mental health in women

The current study attempts to measure the difference in mood, functional status, and leisure-time physical activity in women with a history of COVID-19.

17 Jan 2022

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

Researchers determine the driving factors for disease severity and death due to COVID-19.

17 Jan 2022

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Researchers compare the outcomes of the fourth and previous waves of the COVID-19 pandemic in South Africa.

17 Jan 2022

'Presence' of a virtual person can reduce anxiety in women

A lot of people feel less anxious in a frightening situation if they don't have to face it alone. But what if these people suffer from social anxiety - a disorder characterized by fears of embarrassing themselves in social situations?

17 Jan 2022

Lifestyle interventions for preschool children can enhance long-term cardiovascular health status

Implementing school-based programs aimed at teaching healthy cardiovascular health habits as early as preschool can achieve lasting lifestyle changes in children, according to a review published today in the Journal of the American College of Cardiology.

17 Jan 2022

Medical Condition News

New MRI technique could pave the way to quicker assessment of multiple sclerosis

New pathways responsible for hepatocellular carcinoma identified

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Risk factors affect cardiovascular disease risk even in patients with no coronary artery calcium

NIH launches first phase of the Neuromod Prize to develop new neuromodulation therapies

In-jail buprenorphine treatment for opioid use disorder may reduce rearrest and reconviction

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

Arterial stiffness in adolescence may be a causal risk factor for insulin resistance and dyslipidemia

Wastewater-based epidemiology to predict emerging new SARS-CoV-2 variants

Chinese scientists reveal key role of lysosome cell death regulator in lung tumor survival

ACP guidelines: Uncomplicated diverticulitis can be treated in an outpatient setting without antibiotics

New blood test for glioblastoma diagnosis may soon be a reality

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

DPP4 protein: The connection between severe COVID-19 and diabetes

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Effects of post-acute COVID-19 on physical and mental health in women

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

'Presence' of a virtual person can reduce anxiety in women

Lifestyle interventions for preschool children can enhance long-term cardiovascular health status

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News